These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12760873)

  • 41. Disposition of norfloxacin in broiler chickens and turkeys after different methods of oral administration.
    Sárközy G; Semjén G; Laczay P
    Vet J; 2004 Nov; 168(3):312-6. PubMed ID: 15501149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Convulsant and subconvulsant doses of norfloxacin in the presence and absence of biphenylacetic acid alter extracellular hippocampal glutamate but not gamma-aminobutyric acid levels in conscious rats.
    Smolders I; Gousseau C; Marchand S; Couet W; Ebinger G; Michotte Y
    Antimicrob Agents Chemother; 2002 Feb; 46(2):471-7. PubMed ID: 11796360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absorption of ciprofloxacin and norfloxacin when administered as niosome-encapsulated inclusion complexes.
    D'Souza SA; Ray J; Pandey S; Udupa N
    J Pharm Pharmacol; 1997 Feb; 49(2):145-9. PubMed ID: 9055185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.
    Aeschlimann JR; Kaatz GW; Rybak MJ
    J Antimicrob Chemother; 1999 Sep; 44(3):343-9. PubMed ID: 10511401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor using different topical application modes.
    Beck R; van Keyserlingk J; Fischer U; Guthoff R; Drewelow B
    Graefes Arch Clin Exp Ophthalmol; 1999 Feb; 237(2):89-92. PubMed ID: 9987622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative bioavailability of two brands of norfloxacin.
    Seth SD; Beotra A; Seth S
    J Assoc Physicians India; 1995 May; 43(5):324-6. PubMed ID: 9081960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensitive high-performance liquid chromatographic assay for norfloxacin utilizing fluorescence detection.
    Hussain MS; Chukwumaeze-Obiajunwa V; Micetich RG
    J Chromatogr B Biomed Appl; 1995 Jan; 663(2):379-84. PubMed ID: 7735486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steady-state levels of pefloxacin and its metabolites in patients with severe renal impairment.
    Jungers P; Ganeval D; Hannedouche T; Prieur B; Montay G
    Eur J Clin Pharmacol; 1987; 33(5):463-7. PubMed ID: 3480804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose ranging pharmacokinetics and brain distribution of norfloxacin using microdialysis in rats.
    Marchand S; Chenel M; Lamarche I; Pariat C; Couet W
    J Pharm Sci; 2003 Dec; 92(12):2458-65. PubMed ID: 14603491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat.
    Bol CJJG ; Danhof M; Stanski DR; Mandema JW
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1051-8. PubMed ID: 9399976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats.
    Della Paschoa OE; Mandema JW; Voskuyl RA; Danhof M
    J Pharmacol Exp Ther; 1998 Feb; 284(2):460-6. PubMed ID: 9454785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
    Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
    J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic-pharmacodynamic analysis of fluoroquinolones against Bacillus anthracis.
    Kihira T; Sato J; Shibata T
    J Infect Chemother; 2004 Apr; 10(2):97-100. PubMed ID: 15160302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nociceptive stimulus modality-related difference in pharmacokinetic-pharmacodynamic modeling of morphine in the rat.
    Shang GW; Liu DN; Yan LH; Cui XY; Zhang KP; Qi C; Chen J
    Pharmacol Biochem Behav; 2006 Oct; 85(2):464-73. PubMed ID: 17126387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for erythropenia in rats.
    Kobuchi S; Ito Y; Hayakawa T; Nishimura A; Shibata N; Takada K; Sakaeda T
    J Pharmacol Toxicol Methods; 2014; 70(2):134-44. PubMed ID: 25072509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Norfloxacin exhibits negligible serum concentrations after repeated conjunctival instillation in children.
    Drago F; La Manna C; Marino V; Marino A; Emmi I; Reibaldi A
    Br J Clin Pharmacol; 1998 Sep; 46(3):272-4. PubMed ID: 9764971
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparative studies on the pharmacokinetics of norfloxacin in chickens, turkeys and geese after a single oral administration.
    Laczay P; Semjén G; Nagy G; Lehel J
    J Vet Pharmacol Ther; 1998 Apr; 21(2):161-4. PubMed ID: 9597656
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacokinetic-pharmacodynamic modelling of tiagabine CNS effects upon chronic treatment in rats: lack of change in concentration-EEG effect relationship.
    Cleton A; Altorf BA; Voskuyl RA; Danhof M
    Eur J Pharm Sci; 2000 Dec; 12(2):141-50. PubMed ID: 11102742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Penetration of pefloxacin and its desmethyl metabolite into the uroepithelium after a 800-mg single oral dose in human patients.
    Moreau JL; Royer-Morrot MJ; Lozniewski A; Trackoen G; Delavault P; Royer RJ
    Eur J Clin Pharmacol; 1996; 49(5):401-5. PubMed ID: 8866637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of rufloxacin and norfloxacin effects on faecal flora.
    Marco F; Giménez MJ; Jiménez de Anta MT; Marcos MA; Salvá P; Aguilar L
    J Antimicrob Chemother; 1995 Jun; 35(6):895-901. PubMed ID: 7559202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.